HKU COVID-19 vaccine trials to start in July
Share - WeChat

A COVID-19 vaccine developed by the University of Hong Kong is expected to begin human trials in July, according to He Yiwu, who leads the HKU vaccine team. However, he told China Daily on Monday that border control could slow down the vaccine manufacturing process as the city must rely on mainland manufacturers. He called for a green channel to facilitate mainland-Hong Kong collaboration in vaccine development.
- Police called in after investigation into food safety incident at Shanghai schools
- Shanghai Sports Festival sparks citywide fitness fun
- Intl conference shows new pathways to integrate education, research and application
- China's cyberspace regulator penalizes Toutiao for presenting 'harmful information'
- Shanghai's first intl snow sculpture expo transforms resort into winter wonderland
- China-built jet C919 carries out over 2 million passenger trips